We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Imaging Technique Offers Hope for Real-Time Histology

By LabMedica International staff writers
Posted on 13 Dec 2010
Researchers have used a novel microscope-based imaging technique to differentiate between cancer cells and normal cells in living tissue without the need for time-consuming histological procedures.

Investigators at the University of Illinois (Urbana-Champaign, USA) used lipid and protein specific microscopic probes in conjunction with a novel technique called nonlinear interferometric vibrational imaging (NIVI).

The probes were used to label lipid-rich normal cells and protein-rich cancer cells within living rat tissues. More...
By combining two different light sources, the microscope produced colored images that defined normal and cancerous areas within the tissue.

Results published in the November 23, 2010, online edition of the journal Cancer Research revealed that the technique was able to provide easy-to-read, color-coded images of the tissue, with more than 99% confidence, in less than five minutes. Particularly impressive was the technique's ability to outline tumor boundaries clearly.

"Sometimes it is very hard to tell visually whether a cell is normal or abnormal,” said senior author Dr. Stephen A. Boppart, professor of bioengineering and medicine at the University of Illinois. "But molecularly, there are fairly clear signatures.”

"The diagnosis is made based on very subjective interpretation - how the cells are laid out, the structure, the morphology,” said Dr. Boppart. "This is what we call the gold standard for diagnosis. We want to make the process of medical diagnostics more quantitative and more rapid. As we get better spectral resolution and broader spectral range, we can have more flexibility in identifying different molecules. Once you get to that point, we think it will have many different applications for cancer diagnostics, for optical biopsies, and other types of diagnostics.”

Related Links:
University of Illinois




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
D-Dimer Test
Epithod 616 D-Dimer Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.